韩国院外心脏骤停院前肾上腺素给药时机与患者结局的关联:一项全国性观察性研究
经1:1倾向评分匹配后(n=5734),延迟给药与较低的出院生存率(4.46% vs 7.74%;aOR 0.56,95%CI 0.44-0.71)和较低的良好神经功能结局率(2.13% vs 3.77%;aOR 0.56,95%CI 0.40-0.79)相关。连续模型显示每延迟1分钟良好CPC几率降低(aOR 0.964,95%CI 0.942-0.987),5分钟延迟aOR 0.833(95%CI 0.741-0.937),超过30分钟下降更显著(aOR 0.048,95%CI 0.006-0.393)。结论支持及时实施高级生命支持包括早期肾上腺素的重要性,但需谨慎解读。
要点
- 在匹配队列中,心脏骤停后>20分钟给肾上腺素较≤20分钟组出院生存率更低(4.46% vs 7.74%;aOR 0.56,95%CI 0.44-0.71)。
- 延迟给药组良好神经功能结局(CPC 1-2)率更低(2.13% vs 3.77%;aOR 0.56,95%CI 0.40-0.79)。
- 每延迟1分钟给肾上腺素,良好神经功能结局几率降低(aOR 0.964,95%CI 0.942-0.987);5分钟延迟aOR 0.833(95%CI 0.741-0.937)。
- 给药时间超过30分钟与良好神经功能结局几率显著下降相关(aOR 0.048,95%CI 0.006-0.393)。
- 该研究为观察性设计,结果支持及时给予肾上腺素,但需谨慎解读,不能直接推断因果关系。
适用人群与场景
- 韩国EMS治疗的非创伤性成人院外心脏骤停患者,研究期间为2019-2021年。
- 纳入标准:EMS治疗的成人(年龄未在原文明确)、非创伤性OHCA。排除标准:原文未提及。
- 场景为院前急救,病情阶段为心脏骤停后 advanced life support 期间。
诊断标准与关键阈值
- 按心脏骤停至首次肾上腺素时间分组:早期≤20分钟,延迟>20分钟。
- 主要结局:出院时良好神经功能状态,定义为脑功能分级(CPC)1-2。
- 次要结局:自主循环恢复(ROSC)和出院生存。
处置流程与药物剂量
- 原文未提及具体肾上腺素剂量、给药途径、频次或目标值。
- 原文仅关注给药时机:心脏骤停后20分钟内给予肾上腺素与更好结局相关。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 干预与对照:早期肾上腺素(≤20分钟)vs 延迟肾上腺素(>20分钟),采用1:1倾向评分匹配和多变量logistic回归。
- 主要终点:良好神经功能结局(CPC 1-2)在延迟组更低(2.13% vs 3.77%;aOR 0.56,95%CI 0.40-0.79)。
- 关键次要终点:出院生存率延迟组更低(4.46% vs 7.74%;aOR 0.56,95%CI 0.44-0.71);ROSC结果原文未提供具体数值。
- 连续分析:每延迟1分钟良好CPC的aOR 0.964(95%CI 0.942-0.987);5分钟延迟aOR 0.833(95%CI 0.741-0.937);>30分钟aOR 0.048(95%CI 0.006-0.393)。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:回顾性观察性队列研究(全国性)。
- 证据等级或推荐强度:原文未提及。
- 局限:观察性设计可能存在残余混杂;原文未提及单中心、开放标签等具体局限,但设计本身为回顾性、非随机化。
对床旁实践的改变
- 在院前EMS环境中,对于非创伤性成人OHCA,应尽早给予肾上腺素(心脏骤停后20分钟内),以可能提高ROSC、出院生存率和良好神经功能结局。
- 每延迟1分钟给药与良好神经结局几率降低相关,提示应优化流程减少给药延迟。
- 该研究为观察性研究,不能证明因果关系,临床决策需结合具体情况和指南。
- 原文未提供具体药物剂量和给药方案,不能据此改变剂量实践。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The optimal timing of epinephrine during out-of-hospital cardiac arrest (OHCA) remains uncertain, particularly for neurological recovery. We examined the association between time-to-epinephrine and clinical outcomes in adult OHCA in Korea.
METHODS: We conducted a nationwide retrospective cohort of emergency medical service (EMS)-treated, non-traumatic adult OHCA (2019-2021). Patients were classified as early (≤20 min) or delayed (>20 min) based on arrest-to-first epinephrine. The primary outcome was favourable neurological status at discharge (Cerebral Performance Category (CPC) 1-2); secondary outcomes were return of spontaneous circulation (ROSC) and survival to discharge. We applied 1:1 propensity-score matching and multivariable logistic regression, including continuous (per 1-minute and 5-minute delays) and 5-minute bin analyses of time-to-epinephrine, with effect modification assessed by initial rhythm.
RESULTS: Among 10 726 patients, 3589 (33.5%) received epinephrine within 20 min. In the matched cohort (n = 5,734), delayed administration was associated with lower survival (4.46% vs 7.74%; aOR 0.56, 95% CI 0.44-0.71) and lower likelihood of favourable neurological outcome (2.13% vs 3.77%; aOR 0.56, 95% CI 0.40-0.79), compared with early administration. In continuous models, each 1-minute delay was associated with lower odds of good CPC (aOR 0.964, 95% CI 0.942 to 0.987); a 5-minute delay corresponded to aOR 0.833 (95% CI 0.741 to 0.937) and bin-wise estimates showed a marked drop beyond 30 min (aOR 0.048, 95% CI 0.006 to 0.393).
CONCLUSION: Early epinephrine administration within 20 min of cardiac arrest onset was associated with higher rates of ROSC, survival to discharge and favourable neurological recovery in this EMS setting. These findings support the importance of timely advanced life support delivery, including early epinephrine, although cautious interpretation is warranted.
参考来源
- Lee SH, Hong WP, Park JH, et al. Association between the timing of prehospital epinephrine administration and patient outcomes after out-of-hospital cardiac arrest in Korea: a nationwide observational study. Emerg Med J. 2026. PMID: 42493234. doi:10.1136/emermed-2025-215848
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。